
Gurmit Singh Chugh
About Gurmit Singh Chugh
Data last updated:
Gurmit Singh Chugh is a Director at Integris Medtech Limited (since 2008), Whole-Time Director at Transhealth Private Limited (since 2020) and Director at Aerobiotix Global Private Limited (since 2025), and holds 10 more current directorships. The companies operate in Healthcare, Consumer Services and Financial Services. The 8 current companies with reported revenue have a combined latest revenue of ₹2,016 Cr; the largest is Integris Medtech Limited at ₹1,960 Cr (FY 2025). Earlier, Gurmit Singh Chugh was a Director at Ae-Research Private Limited (2009–2012) and Director at Translumina Therapeutics Private Limited (from 2009) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Apr 2008 | 2008 | ₹1,960 Cr (FY 2025) | Active | |
| Whole-Time Director | 02 Jun 2020 | 2020 | ₹38.92 Cr (FY 2024) | Active | |
| Director | 06 Sep 2025 | 2019 | ₹8.97 Cr (FY 2024) | Active | |
| Director | 24 Jun 2025 | 2021 | ₹5.46 Cr (FY 2024) | Active | |
| Director | 20 Apr 2021 | 2021 | ₹1.94 Cr (FY 2024) | Active | |
| Director | 31 Aug 2022 | 2022 | ₹1.28 Cr (FY 2025) | Active | |
| Director | 28 Feb 2022 | 1996 | ₹85,367 (FY 2021) | Active | |
| Director | 11 Nov 2021 | 2021 | ₹10,000 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Aug 2009 | 2009 | ₹6.11 Cr (FY 2024) | Active | |
| Director | 21 Oct 2009 | 2009 | Converted To Llp | ||
| Managing Director | 01 Apr 2004 | 2002 | ₹2 Lakh (FY 2023) | Converted To Llp | |
| Partner | 17 May 2019 | 2009 | ₹376 Cr (FY 2023) | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Gurmit Singh Chugh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurmit Singh Chugh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurmit Singh Chugh
Gurmit Singh Chugh currently holds 13 directorships: Integris Medtech Limited (Director, since 25 Apr 2008, revenue ₹1,960 Cr (FY 2025)); Transhealth Private Limited (Whole-Time Director, since 02 Jun 2020, revenue ₹38.92 Cr (FY 2024)); Aerobiotix Global Private Limited (Director, since 06 Sep 2025, revenue ₹8.97 Cr (FY 2024)); Halemed Medical Private Limited (Director, since 24 Jun 2025, revenue ₹5.46 Cr (FY 2024)); Whitestone Estate Private Limited (Director, since 20 Apr 2021, revenue ₹1.94 Cr (FY 2024)); and 8 more.
Gurmit Singh Chugh was first appointed on 01 Apr 2004 as Managing Director at Advance Therapeutics Private Limited. The most recent appointment on record is 17 Sep 2025 at Translumina Therapeutics Private Limited.
The 8 current companies of Gurmit Singh Chugh that report revenue have a combined latest revenue of ₹2,016 Cr: Integris Medtech Limited ₹1,960 Cr (FY 2025); Transhealth Private Limited ₹38.92 Cr (FY 2024); Aerobiotix Global Private Limited ₹8.97 Cr (FY 2024); Halemed Medical Private Limited ₹5.46 Cr (FY 2024); Whitestone Estate Private Limited ₹1.94 Cr (FY 2024); and 3 more.
Gurmit Singh Chugh held 4 earlier board appointments: Ae-Research Private Limited (Director, 11 Aug 2009 to 17 Dec 2012); Translumina Therapeutics Private Limited (Director, from 21 Oct 2009); Advance Therapeutics Private Limited (Managing Director, from 01 Apr 2004); Translumina Therapeutics Llp (Partner, from 17 May 2019).
The current boards of Gurmit Singh Chugh's companies include Annaswamy Vaidheesh (Integris Medtech Limited), Arjun Oberoi (Integris Medtech Limited), Avnish Mehra (Integris Medtech Limited), Darpan Batra (Integris Medtech Limited), Hemant Sultania (Integris Medtech Limited), Probir Das (Integris Medtech Limited), among others.